No evidence of occult HBV infection in population born after mass vaccination
Sign Up to like & getrecommendations! Published in 2020 at "Wiener Medizinische Wochenschrift"
DOI: 10.1007/s10354-020-00748-z
Abstract: Despite access to efficient hepatitis B virus (HBV) vaccine and universal immunization schedules, HBV infection remains a global health concern. HBV infection has decreased by this program. Nevertheless, breakthrough infections occur due to generation of occult HBV… read more here.
Keywords: infection; hbv infection; anti hbc; population ... See more keywords
Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance
Sign Up to like & getrecommendations! Published in 2021 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-021-06845-2
Abstract: We investigated the efficiency of the indirect ratio of anti-HBc IgG at predicting HBsAg seroclearance in patients with nucleos(t)ide analogue (NA)-induced HBeAg seroclearance. We performed a retrospective study that included 366 chronic hepatitis B patients… read more here.
Keywords: seroclearance; anti hbc; hbc igg; hbsag seroclearance ... See more keywords
Neonatal hepatitis B vaccination protects mature adults from occult virus infection
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology International"
DOI: 10.1007/s12072-021-10156-z
Abstract: Among elder children/young adults who received hepatitis B virus (HBV) vaccination during infancy, the serological status of HBsAg-negative and anti-HBc-positive [HBsAg(–)/anti-HBc(+)] was frequently reported, indicating potential occult HBV infection (OBI). It is required to define… read more here.
Keywords: hepatitis; hbsag anti; hbv; group ... See more keywords
Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the Formosan Medical Association = Taiwan yi zhi"
DOI: 10.1016/j.jfma.2017.11.012
Abstract: BACKGROUND/PURPOSE The predictors of off-therapy response in patients treated with neucleos(t)ide analogue (NA) have not been elucidated. It remained unexplored whether serum level of hepatitis B core antibody (anti-HBc) at the end of NA therapy… read more here.
Keywords: core antibody; chronic hepatitis; hepatitis; relapse ... See more keywords
Prevalence of anti-hepatitis B core in men who have sex with men attending a sexual health clinic in Brighton, UK, from 2012 to 2019.
Sign Up to like & getrecommendations! Published in 2022 at "Sexual health"
DOI: 10.1071/sh22120
Abstract: OBJECTIVE Hepatitis B is sexually transmitted among men who have sex with men (MSM) and has previously been endemic in some populations of MSM. Presence of anti-hepatitis B core (anti-HBc) determines previous or ongoing infection.… read more here.
Keywords: 2012 2019; anti hbc; prevalence; hepatitis ... See more keywords
HEPATITIS B IMMUNOGLOBULIN PROPHYLAXIS FOR PREVENTION OF DE NOVO HEPATITIS B INFECTION FROM HEPATITIS B CORE ANTIBODY-POSITIVE DONORS
Sign Up to like & getrecommendations! Published in 2020 at "Transplantation"
DOI: 10.1097/01.tp.0000701348.41608.48
Abstract: Introduction: Recently, hepatitis B core antibody (anti-HBc) positive liver grafts are used as extended criteria donor organs. However, prophylaxis methods to prevent de novo hepatitis B virus (HBV) infection after liver transplantation (LT) are still… read more here.
Keywords: core antibody; hepatitis; infection; hbc positive ... See more keywords
The hepatitis B core antibody positive/hepatitis B surface antigen negative pattern is associated with the increased risk of intracranial atherosclerotic stenosis
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000018752
Abstract: Abstract The high prevalence of hepatitis B virus (HBV) infection and intracranial atherosclerotic stenosis (ICAS) in Asia raises the question as to whether HBV infection is associated with ICAS. To answer this question, we tested… read more here.
Keywords: hbsag; infection; icas; hepatitis ... See more keywords
Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen–negative Patients Undergoing Kidney Transplantation
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation"
DOI: 10.1097/tp.0000000000002173
Abstract: Background The American Gastroenterological Association and European Association for the Study of the Liver recommend that hepatitis B surface antigen (HBsAg)–negative and hepatitis B core antibody (anti-HBc)–positive patients who receive immunosuppression should be monitored for… read more here.
Keywords: hepatitis; anti hbc; hbc anti; anti hbs ... See more keywords
What is the clinical impact of occult HBV infections and anti‐HBc positivity in patients with chronic hepatitis C?
Sign Up to like & getrecommendations! Published in 2022 at "Microbiology and Immunology"
DOI: 10.1111/1348-0421.13012
Abstract: Occult hepatitis B infection (OBI) is defined by the persistence of the hepatitis B virus (HBV) genome in the liver of individuals testing negative for hepatitis B surface antigen (HBsAg). Hepatitis B core antibody (anti‐HBc)… read more here.
Keywords: patients chronic; hbv; chronic hepatitis; hepatitis ... See more keywords
Anti‐HBc‐nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13733
Abstract: Absence of anti‐HBc reactivity with detectable anti‐HBs was observed in blood donors with occult hepatitis B virus (HBV) infection (OBI). The prevalence and mechanisms underlying this uncommon condition were investigated over time in Chinese blood… read more here.
Keywords: hbs; anti hbs; hepatitis; isolated anti ... See more keywords
Kinetics and predictive value of HBcrAg, HBV RNA and anti‐HBc during bulevirtide treatment of chronic HDV‐infected patients
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13804
Abstract: The entry inhibitor bulevirtide (BLV) is a new treatment option for patients with chronic hepatitis D virus (HDV) infection and compensated liver disease. The aim of this study was to investigate the kinetic and predictive… read more here.
Keywords: anti hbc; treatment; hbv rna; hdv ... See more keywords